Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 38

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression

van den Boogert, Marjolein A.W., Larsen, Lars E., Ali, Lubna, Kuil, Sacha D., Chong, Patrick L.W., Loregger, Anke, Kroon, Jeffrey, Schnitzler, Johan G., Schimmel, Alinda W.M., Peter, Jorge, Levels, Johannes H.M., Steenbergen, Gerry, Morava, Eva, Dallinga-Thie, Geesje M., Wevers, Ron A., Kuivenhoven, Jan Albert, Hand, Nicholas J., Zelcer, Noam, Rader, Daniel J., Stroes, Erik S.G., Lefeber, Dirk J., Holleboom, Adriaan G. · 2019 · Circulation

Abstract

Background: The importance of protein glycosylation in regulating lipid metabolism is becoming increasingly apparent. We set out to further investigate this by studying patients with type I congenital disorders of glycosylation (CDGs) with defective N-glycosylation. Methods: We studied 29 patients with the 2 most prevalent types of type I CDG, ALG6 (asparagine-linked glycosylation protein 6)–deficiency CDG and PMM2 (phosphomannomutase 2)–deficiency CDG, and 23 first- and second-degree relatives with a heterozygous mutation and measured plasma cholesterol levels. Low-density lipoprotein (LDL) metabolism was studied in 3 cell models—gene silencing in HepG2 cells, patient fibroblasts, and patient hepatocyte-like cells derived from induced pluripotent stem cells—by measuring apolipoprotein B production and secretion, LDL receptor expression and membrane abundance, and LDL particle uptake. Furthermore, SREBP2 (sterol regulatory element-binding protein 2) protein expression and activation and endoplasmic reticulum stress markers were studied. Results: We report hypobetalipoproteinemia (LDL cholesterol [LDL-C] and apolipoprotein B below the fifth percentile) in a large cohort of patients with type I CDG (mean age, 9 years), together with reduced LDL-C and apolipoprotein B in clinically unaffected heterozygous relatives (mean age, 46 years), compared with 2 separate sets of age- and sex-matched control subjects. ALG6 and PMM2 deficiency led to markedly increased LDL uptake as a result of increased cell surface LDL receptor abundance. Mechanistically, this outcome was driven by increased SREBP2 protein expression accompanied by amplified target gene expression, resulting in higher LDL receptor protein levels. Endoplasmic reticulum stress was not found to be a major mediator. Conclusions: Our study establishes N-glycosylation as an important regulator of LDL metabolism. Given that LDL-C was also reduced in a group of clinically unaffected heterozygotes, we propose that increasing LDL receptor–mediated cholesterol clearance by targeting N-glycosylation in the LDL pathway may represent a novel therapeutic strategy to reduce LDL-C and cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.118.036484

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 45

  1. 10.1097/MOL.0000000000000461 · DOI
  2. 10.1016/j.cell.2006.08.019 · DOI · Paper page
  3. 10.1038/ng.291 · DOI · Paper page
  4. 10.1016/j.cmet.2011.11.005 · DOI
  5. 10.1074/jbc.M110.156950 · DOI
  6. 10.1016/j.cmet.2016.07.012 · DOI
  7. 10.1016/j.ajhg.2013.10.024 · DOI · Paper page
  8. 10.1111/j.1749-6632.2010.05840.x · DOI · Paper page
  9. 10.1007/s10545-014-9720-9 · DOI
  10. 10.1016/j.bbadis.2008.11.012 · DOI
  11. 10.1016/S0140-6736(87)91287-6 · DOI · Paper page
  12. 10.1016/S0387-7604(12)80276-2 · DOI
  13. 10.1007/BF00873975 · DOI
  14. 10.1007/s10545-011-9370-0 · DOI
  15. 10.1074/jbc.M203285200 · DOI
  16. 10.1016/S0925-4439(99)00072-1 · DOI
  17. 10.1002/hep.25871 · DOI
  18. 10.1093/eurheartj/ehs472 · DOI
  19. 10.1172/JCI32752 · DOI · Paper page
  20. 10.1155/2012/610741 · DOI
  21. 10.1074/jbc.M410302200 · DOI · Paper page
  22. 10.1007/s00018-005-4473-0 · DOI
  23. 10.1023/A:1013944308881 · DOI
  24. 10.1161/ATVBAHA.108.181859 · DOI
  25. 10.1074/jbc.272.33.20427 · DOI · Paper page
  26. 10.1016/S0021-9258(19)42341-7 · DOI · Paper page
  27. 10.1073/pnas.93.11.5437 · DOI
  28. 10.1074/jbc.M408235200 · DOI · Paper page
  29. 10.1172/JCI11596 · DOI · Paper page
  30. 10.1074/jbc.M116.744235 · DOI
  31. 10.1016/s0092-8674(00)80213-5 · DOI · Paper page
  32. 10.1093/clinchem/42.4.515 · DOI · Paper page
  33. 10.1161/ATVBAHA.109.194191 · DOI
  34. 10.1074/jbc.M606495200 · DOI · Paper page
  35. 10.1016/S0022-2275(20)32192-1 · DOI
  36. 10.1042/0264-6021:3530493 · doi:10.1042/0264-6021:3530493
  37. 10.1194/jlr.m200077-jlr200 · DOI
  38. 10.1073/pnas.262669399 · DOI
  39. van den Boogert, MAW, Kuil, SD, Hovingh, GK, Motazacker, MM, Levels, JHM, Dallinga-Thie, GM, Kuivenhoven, JA, Wevers, R, Stroes, ESG, Lefeber, DJ, et al. Genetic defects in protein glycosylation as a cause of dyslipidemia. Poster presented at: American Heart Association Scientific Sessions in the Best of Basic Science Session; November 16–20, 2013; Dallas, TX.
  40. 10.1016/j.ajhg.2015.12.010 · DOI
  41. 10.1016/j.ajhg.2015.12.011 · DOI
  42. 10.1038/emboj.2013.79 · DOI · Paper page
  43. Jaeken, J, Matthijs, G, Carchon, H, Van Schaftingen, E. 2001 defects of N-glycan synthesis. Scriver, C, Beaudet, A, Sly, WS, Valle, D, eds. In: The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill:1601–1622
  44. 10.1126/science.1235681 · DOI · Paper page
  45. 10.1038/nj7661-127a · doi:10.1038/nj7661-127a

Cited by

See all 38

Metadata

Authors
van den Boogert, M. A. W., Larsen, L. E., Ali, L., Kuil, S. D., Chong, P. L. W., Loregger, A., Kroon, J., Schnitzler, J. G., Schimmel, A. W. M., Peter, J., Levels, J. H. M., Steenbergen, G., Morava, E., Dallinga-Thie, G. M., Wevers, R. A., Kuivenhoven, J. A., Hand, N. J., Zelcer, N., Rader, D. J., Stroes, E. S. G., Lefeber, D. J., & Holleboom, A. G.
Affiliations
  • Departments of Vascular Medicine (M.A.W.v.d.B., J.K., G.M.D.-T., E.S.G.S., A.G.H.), Amsterdam University Medical Centers, location AMC, The Netherlands.
  • Experimental Vascular Medicine (M.A.W.v.d.B., L.E.L., L.A., P.L.W.C., J.K., J.G.S., A.W.M.S., J.P., J.H.M.L., G.M.D.-T.), Amsterdam University Medical Centers, location AMC, The Netherlands.
  • Department of Laboratory Medicine, Translational Metabolic Laboratory (S.D.K., G.S., R.A.W., D.J.L.), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Medical Biochemistry (A.L., N.Z.), Amsterdam University Medical Centers, location AMC, The Netherlands.
  • Department of Clinical Genomics, Mayo Clinic, Rochester, MN (E.M.).
  • Department of Pediatrics, Section Molecular Genetics, University Medical Center Groningen, University of Groningen, The Netherlands (J.A.K.)
  • Department of Genetics and Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (L.E.L., P.L.W.C., N.J.H., D.J.R.).
Venue
Circulation
Published
2019-07-23
Volume
140
Issue
4
Pages
280-292
ISSN
  • 0009-7322
  • 1524-4539
Cited by
38
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression. https://app.cochat.ai/papers/10.1161/circulationaha.118.036484
The paper
van den Boogert, M. A. W., Larsen, L. E., Ali, L., Kuil, S. D., Chong, P. L. W., Loregger, A., Kroon, J., Schnitzler, J. G., Schimmel, A. W. M., Peter, J., Levels, J. H. M., Steenbergen, G., Morava, E., Dallinga-Thie, G. M., Wevers, R. A., Kuivenhoven, J. A., Hand, N. J., Zelcer, N., Rader, D. J., . . . Holleboom, A. G. (2019). N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression. Circulation. https://doi.org/10.1161/circulationaha.118.036484

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.